Overview

Lactobacillus Acidophilus and Bifidobacterium Animalis Subsp. Lactis, Maintenance Treatment in Ulcerative Colitis

Status:
Terminated
Trial end date:
2007-03-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to determine whether the lactic acid bacteria " Lactobacillus acidophilus (LA5) and Bifidobacterium animalis subsp. lactis (BB12)" is effective as maintenance treatment in ulcerative colitis.
Phase:
Phase 2
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Hvidovre University Hospital
Collaborators:
Chr Hansen
Chr Hansen A/S
Criteria
Inclusion Criteria:

- Patients with ulerative colitis ording to well-known diagnostic criteria and remission
for at least one month, and with at least one relapse within the last year.

Exclusion Criteria:

- Pregnancy and lactating

- Serious underlying disease other than UC

- Former gastrointestinal resections

- Medication for UC other than mesalazine

- Known allergic reactions towards compounds in the study drug.

- Expected lack of compliance due to mental state or language problems